In laboratory platelet testing, amidated PAR1 and PAR4 activating peptides were more potent than free-acid forms (median EC50 2.6–12.6 and 4.7–10 times lower); PAR4-AP-OH did not reach maximal activation for several markers. ISTH SSC advises reporting full peptide structure.
Guideline
Boukhatem et al. Impact of C-terminal amidation on platelet activation by protease-activated receptors 1 and 4 activating peptides: communication from the ISTH SSC Subcommittee on Platelets in Health and Disease